BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30801786)

  • 1. Low dose acitretin versus methotrexate in the treatment of palmoplantar psoriasis: a case series.
    Gisondi P; Mattiucci A; Tonin B; Girolomoni G
    J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):e246-e247. PubMed ID: 30801786
    [No Abstract]   [Full Text] [Related]  

  • 2. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
    An J; Zhang D; Wu J; Li J; Teng X; Gao X; Li R; Wang X; Xia L; Xia Y
    Pharmacol Res; 2017 Jul; 121():158-168. PubMed ID: 28414177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with drug survival of methotrexate and acitretin in patients with psoriasis.
    Shalom G; Zisman D; Harman-Boehm I; Biterman H; Greenberg-Dotan S; Polishchuk I; Moser H; Freud T; Feldhamer I; Cohen AD
    Acta Derm Venereol; 2015 Nov; 95(8):973-7. PubMed ID: 25950855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional therapies for psoriasis.
    Rebora A
    Reumatismo; 2007; 59 Suppl 1():77-80. PubMed ID: 17828351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verrucous psoriasis treated with methotrexate and acitretin combination therapy.
    Shivers L; Montanez-Wiscovich ME
    Cutis; 2019 Dec; 104(6):E10-E12. PubMed ID: 31939936
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis.
    Kuijpers AL; van Dooren-Greebe JV; van de Kerkhof PC
    Dermatology; 1997; 194(1):88-90. PubMed ID: 9031805
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential therapy using cyclosporine and acitretin for treatment of total body psoriasis.
    Short MW; Vaughan TK
    Cutis; 2004 Sep; 74(3):185-8. PubMed ID: 15499760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Psoriasis Therapies.
    James J; Otto T; Gao J; Porter ML
    Dermatol Clin; 2024 Jul; 42(3):357-363. PubMed ID: 38796267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psoriasis].
    Guilhou JJ; Girard C
    Rev Prat; 2006 Dec; 56(19):2153-8. PubMed ID: 17416055
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate versus Acitretin in the Treatment of Chronic Hand Dermatitis.
    O'Shea PM; Lugo-Somolinos A
    J Drugs Dermatol; 2015 Dec; 14(12):1389-91. PubMed ID: 26659930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmoplantar pustular psoriasis following initiation of a beta-blocker: disease control with low-dose methotrexate.
    Stanford CW; Kollipara R; Melookaran AM; Hall JC
    Cutis; 2014 Sep; 94(3):153-5. PubMed ID: 25279477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent use of methotrexate and acitretin revisited.
    Lowenthal KE; Horn PJ; Kalb RE
    J Dermatolog Treat; 2008; 19(1):22-6. PubMed ID: 18273721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
    Janagond AB; Kanwar AJ; Handa S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study.
    Ergun T; Seckin Gencosmanoglu D; Alpsoy E; Bulbul-Baskan E; Saricam MH; Salman A; Onsun N; Sarioz A
    J Dermatol; 2017 Jun; 44(6):630-634. PubMed ID: 27943425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and systemic therapy.
    van de Kerkhof P
    Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acitretin for the treatment of psoriasis: an assessment of national trends.
    Ghasri P; Yentzer BA; Dabade TS; Feldman SR
    J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance in psoriasis treatment.
    Kumar B; Saraswat A
    J Am Acad Dermatol; 2001 Jul; 45(1):153-4. PubMed ID: 11423858
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood psoriasis: often favorable outcome.
    Prescrire Int; 2009 Dec; 18(104):275. PubMed ID: 20027717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 'switcher' patient profile in psoriasis treatment: from traditional to biological and from biological to traditional systemic drugs.
    Tabolli S; Giannantoni P; Paradisi A; Abeni D
    Br J Dermatol; 2015 Jul; 173(1):256-8. PubMed ID: 25422080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.